Shrimp Histopathology Lesion Grades and PCR Disagreement

What a shrimp pathology report can actually tell you

A shrimp health report may describe microscopic tissue damage, assign lesion grades and report a polymerase chain reaction result on the same animals. It is tempting to compress everything into one word, infected, or one percentage, disease rate. That can be misleading. Histopathology records what a trained examiner sees in tissue sections; PCR detects specified target nucleic acid under an assay’s conditions; clinical signs describe the animal’s presentation. The three observations overlap, but they are not interchangeable and do not automatically answer the same diagnostic question.

To read shrimp histopathology properly, identify the tissue examined, the sampling unit, the lesion definition, the grading scale and how the specimen was selected. Then identify the PCR target, method, controls, specimen and interpretive rule. A result may support a diagnosis, help investigate a suspected outbreak or contribute to surveillance, but those purposes require different evidence and decision thresholds. The World Organisation for Animal Health provides disease-specific guidance, and professional laboratories must follow their current validated protocols.

This guide focuses on translating and interpreting report language, sample counts and worked calculations. The numerical case studies are explicitly invented for teaching and are not veterinary test results. Nothing here diagnoses disease, instructs a farm to medicate animals or substitutes for competent aquatic animal health assessment, regulated laboratory confirmation or jurisdiction-specific notification duties. The goal is a precise account of what the evidence says, what it suggests and what remains unknown.

First principles: a section, an animal and a population are different units

A histological section is a thin slice of preserved tissue examined under a microscope. Multiple sections can come from one animal; multiple animals can come from one tank; multiple tanks can belong to one farm. If twenty animals each contribute five sections, the pathologist may examine one hundred sections but the sample contains only twenty animals. Reporting ‘twenty percent of sections affected’ is not the same as ‘twenty percent of animals affected’. The denominator defines the claim.

Tissue examination also samples only part of an organism. A pathologist may observe changes in the hepatopancreas, gill, cuticle or another relevant tissue, depending on the question and method. A negative section does not prove that every tissue in the animal is unaffected, and an affected section does not automatically establish which pathogen caused the change. Some patterns can be diagnostically informative, but interpretation depends on lesion specificity, specimen quality and disease context.

Sampling design matters when moving from examined animals to farm-wide prevalence. Forty shrimp taken from a tank because they look ill are a diagnostic convenience sample, not necessarily a random sample of all animals in the pond. Their lesion frequency may be high precisely because sampling targeted abnormal individuals. It is incorrect to extrapolate the observed fraction to all shrimp in the crop without a design that supports that inference.

Write the hierarchy directly on the worksheet: image field belongs to section; section belongs to tissue; tissue belongs to animal; animal belongs to tank; tank belongs to production unit. Errors often arise when the column ‘n’ loses this hierarchy. A count of forty microscope fields from four animals is not forty independently sampled shrimp. Any rate, comparison or confidence interval must respect the actual independent unit.

What a lesion description means and does not mean

A lesion is a tissue change observed relative to an expected state, often described by site, type, severity and distribution. Reports may mention degeneration, necrosis, inflammation, inclusion bodies or other patterns. These words describe morphology; the presence of an organism or pathogen can require additional tests. One visible pattern may be compatible with several causes, while some disease-specific combinations are more informative under validated criteria.

Necrosis generally means cell or tissue death, whereas inflammation describes a host response that can vary among tissues and organisms. A report that mentions both is not redundant: they are different observations. Histopathology can document tissue injury even when a molecular test is negative, but that disagreement can have multiple explanations including different sampling times, different tissues, assay detection limits or an unrelated cause of injury.

An inclusion body is a microscopic cellular feature, not simply a generic symptom. Its appearance, location and relevance depend on the disease and the chosen laboratory criteria. A translator should not replace a specific intranuclear inclusion with the looser expression cell damage, nor assume that every inclusion identifies one virus. Preserve the microscopic description, and leave disease attribution to the specialist’s explicit interpretation.

The words compatible with, suggestive of, presumptive and confirmed express different evidential levels. A lesion may be compatible with a process without proving its cause. A report can give a presumptive diagnosis that requires confirmatory testing under the relevant disease-specific standard. Removing those qualifiers in translation turns measured observations into stronger claims than the laboratory made.

Lesion grades are often ordinal, not quantities of disease

Some pathologists assign scores such as zero, one, two and three to grade observed severity. Such grades are commonly ordinal categories: they establish ordering but not necessarily equal distances. The difference between grades zero and one may not represent the same biological change as the difference between grades two and three. A numerical average can summarise a dataset, but its interpretation depends on the score definition and cannot be treated automatically as a physical unit of tissue destruction.

Before comparing grades, copy the actual grading rubric. Does zero mean no relevant lesion seen in the examined tissue, or a normal control class? Does one describe mild changes, and what specific features qualify? Were sections evaluated blinded to treatment or sampling group? Two laboratories may both use a four-point scale while assigning categories differently. Identical numerals do not make their data directly comparable.

Consider an illustrative group of forty shrimp with grade counts: zero in twenty, one in eight, two in nine and three in three. The total is forty. The proportion with any recorded lesion under this rubric is twenty divided by forty, or 50%. The proportion with grade two or higher is twelve divided by forty, or 30%. These two rates answer different questions. Neither should be called the measured farm disease prevalence without appropriate sampling and diagnostic criteria.

If someone calculates a mean grade of 0.875 from this example, the arithmetic is correct: total score 0 times twenty plus one times eight plus two times nine plus three times three equals thirty-five; divided by forty is 0.875. But the scale is ordinal, so interpretation as a continuous biological distance is not automatically justified. Reporting the category distribution alongside any summary is clearer than relying only on an average score.

Prevalence of lesions depends on the denominator

Suppose forty animals were examined and sixteen had at least one section showing a defined lesion. The animal-level fraction is 16 divided by 40, or 40%. If those animals contributed four sections each, the laboratory examined 160 sections. Imagine thirty sections were judged affected. The section-level fraction is 30 divided by 160, or 18.75%. Both figures can be correct; they describe distinct sampling units and should not replace one another.

Why might sixteen animals generate thirty affected sections? Some animals may have several affected sections, while others have only one. Section counts contain within-animal clustering. Treating 160 sections as independent animals would artificially increase the apparent sample size and potentially produce unjustifiably narrow uncertainty intervals. Statistical analysis should reflect that sections are nested within animals and animals within tanks or farms.

A separate issue is how ‘positive animal’ is defined. A study might classify an animal positive if any one of four sections crosses a lesion threshold, while another requires two sections or a particular tissue. These rules can yield different apparent prevalences on the same raw microscope images. Translation must preserve the rule, not only the final percentage.

When sample selection is targeted at visibly abnormal animals, the lesion frequency is a description of the submitted specimens. It is not a random-sample estimate of the whole pond. A report should say ‘sixteen of forty submitted animals showed the defined lesion’ rather than ‘forty percent of the pond is diseased’. The latter requires population sampling and diagnostic evidence not present in the first statement.

PCR detection is a molecular observation, not an all-purpose diagnosis

PCR assays target particular nucleic-acid sequences. A positive result ordinarily indicates that the assay detected its target under specified test conditions and interpretation rules. This is valuable but does not by itself describe tissue injury, active replication, infectiousness, disease severity or clinical outcome. The strength of the inference depends on target specificity, specimen choice, assay validation and the disease’s diagnostic standard.

An assay report should identify the suspected agent or target, sample type, whether individual animals or pooled specimens were tested, the method and the quality-control result. Negative results require equal care. A target might be absent, present below detection limits or missed because the chosen specimen or timing was unsuitable. ‘Not detected in the submitted sample’ is a safer translation of a negative result than ‘the farm is pathogen-free’.

Some molecular methods yield a cycle threshold or analogous signal. These values depend on platform, assay, specimen preparation and calibration. They are not automatically a universal pathogen load or a direct measure of disease severity. A numeric PCR result must be interpreted using laboratory-specific validation. Copying a cycle threshold from one assay into the interpretive scheme of another can produce false certainty.

WOAH’s aquatic animal standards distinguish surveillance, presumptive diagnosis and confirmatory diagnosis, and disease-specific methods are evaluated for their intended purpose. That framework is especially important when reports move across languages or regulatory systems. A method useful for screening apparently healthy shrimp is not automatically sufficient to confirm a clinical outbreak or support a declaration of freedom from infection.

Why histology and PCR may disagree without either being fraudulent

A positive molecular result with no characteristic lesion may occur when a pathogen is present at an early or low-impact stage, when the sampled section misses an affected focus, or when the molecular signal has another validated interpretation. Conversely, a visible lesion with negative PCR may reflect tissue damage from a different cause, specimen mismatch, sampling time, degradation or test limitations. The specific explanation cannot be chosen from the sign pattern alone.

Picture a shrimp sampled for molecular testing from one tissue while histology is prepared from another. Even if both analyses are technically excellent, they interrogate different biological material. Focal changes in tissue will not necessarily appear uniformly. A report that says ‘PCR and histology disagree’ should tell the reader exactly which tissues, animal identifiers and sampling dates were compared before suggesting an explanation.

The timing of collection also matters. Pathological changes may develop, persist or resolve on a different timeline from detectable nucleic-acid signals. A disease process is dynamic, and a single cross-sectional snapshot captures only one moment. Longitudinal sampling and disease-specific confirmation may improve interpretation, but repeated sampling itself must be planned with appropriate animal-health expertise and biosecurity.

A useful translation describes disagreement as unresolved evidence when that is what it is. For example: ‘Target detected in submitted tissue by the stated PCR assay; no characteristic lesions observed in the examined histology sections.’ This sentence preserves both results and avoids imposing a cause. It leaves room for the qualified laboratory to recommend confirmatory methods under the current standard.

Worked two-by-two table: observe agreement, not imaginary sensitivity

Consider a hypothetical study of forty individually tested shrimp. Ten animals are PCR-positive and lesion-positive, eight are PCR-positive but lesion-negative, two are PCR-negative but lesion-positive, and twenty are negative by both measurements. Check totals: ten plus eight plus two plus twenty equals forty. PCR is positive in eighteen animals, or 45%; histology meets the chosen lesion rule in twelve, or 30%. The two percentages are not interchangeable estimates of true infection prevalence.

Observed agreement is the sum of both-positive and both-negative animals divided by the total: ten plus twenty equals thirty, and thirty divided by forty gives 75%. That is the share where the two classifications match. It does not tell us which test is correct in discordant cases. Without an independent reference standard or appropriate validation framework, sensitivity and specificity of either method cannot be determined from this simple paired table.

The eight PCR-positive, lesion-negative cases do not automatically represent eight false PCR positives. Likewise, the two lesion-positive, PCR-negative cases are not necessarily false negatives. Calling them errors silently assumes one test is an infallible gold standard. The correct labels are discordant classifications under the stated case definitions. Additional diagnostic evidence is needed to attribute the cause.

Even the seventy-five percent agreement depends on the positivity rule used for histology. If the laboratory redefines lesion-positive as grade two or higher, the paired table may change while the underlying sections remain identical. Always state the threshold and rubric beside a reported agreement statistic. Agreement measured under one rule cannot be exported unchanged into another study with different definitions.

Worked lesion matrix: animal-level versus section-level severity

Imagine ten shrimp, each represented by three histology sections. The pathologist assigns the maximum grade seen in each animal: zero, zero, one, one, one, two, two, two, three, three. Under the ‘any lesion’ rule, eight of ten animals are positive, or 80%. Under the ‘grade two or higher’ rule, five of ten are positive, or 50%. Both are correct computations, but the grade threshold changes the question.

Suppose the full thirty-section dataset contains fifteen sections scored zero, six scored one, seven scored two and two scored three. The section-level fraction scoring two or higher is nine divided by thirty, or 30%. This does not contradict the animal-level fifty percent because multiple sections from one animal are not independent and classification may use an animal’s maximum. Without a linked section-to-animal table, one cannot reconstruct the animal-level count reliably from section totals alone.

An audit-friendly worksheet uses one row per animal and separate columns for tissue, section IDs, maximum lesion grade, lesion rule result, PCR result, sample time and missing-data flags. If an animal lacks a usable section, mark that outcome as not evaluable rather than silently entering grade zero. Missing observation is not absence of injury. Similarly, an inhibited molecular assay should not be recoded as a negative result.

Taking a maximum grade can be appropriate for some reporting systems but can also make animals with more sections appear more likely to have a high score. Comparisons should standardise section number and method or address these differences analytically. A summary needs to state whether it used maximum, mean, median or specified tissue-specific grades rather than merely giving one unlabelled disease score.

The quality of fixation, staining and reading affects the claim

Histological interpretation begins long before the microscope. Specimen collection, fixation, processing, embedding, sectioning and staining influence what is visible. Tissue degradation or artefacts can obscure features or mimic damage. A technically poor section may not support a confident negative conclusion even when a slide exists. The report should distinguish ‘no lesions observed in an adequate section’ from ‘section unsatisfactory for interpretation’.

Stain type matters because different stains and methods can reveal different structures. Routine morphology is not the same as immunohistochemistry or in situ hybridisation, which interrogate more specific biological targets. A translation that simply calls every slide a positive microscope test hides a major methodological distinction. Name the test, target and interpretation rule as they appear in the original laboratory report.

Pathologists may disagree over borderline changes, especially when a rubric relies on qualitative judgement. Blinded duplicate readings, training with reference images and consensus procedures can improve consistency. Yet agreement is not the same as accuracy: two observers can share a systematic interpretive bias. Validation and quality assurance remain necessary when high-stakes decisions depend on classifications.

The word ‘severe’ should reflect the stated grading scale or report, not a translator’s emotional emphasis. If the original says moderate changes in a limited proportion of examined sections, rewriting it as extensive severe necrosis can change management response and reporting obligations. Preserve degree, distribution and uncertainty. Clinical and laboratory descriptions have operational meaning and deserve literal scientific discipline.

Disease examples: AHPND and white spot require disease-specific reasoning

Acute hepatopancreatic necrosis disease, abbreviated AHPND, concerns pathogenic strains carrying specified toxin-related determinants and characteristic disease processes, not any generic hepatopancreatic abnormality. WOAH provides an aquatic disease entry and chapter references for appropriate diagnosis. A report about hepatopancreas changes should preserve its microscopic description and testing evidence, rather than automatically labelling all abnormalities AHPND.

White spot syndrome virus, abbreviated WSSV, is another distinct diagnostic question. Histopathology, molecular detection and clinical findings have different strengths at different stages of infection. Research on WSSV diagnostic assays has examined their performance across histological severity grades and documented that molecular detection can occur even where characteristic lesions are not observed. That research supports the general warning against treating one negative modality as a universal exclusion of the other.

An apparent white spot on a shrimp’s surface is not, by itself, a laboratory-confirmed WSSV infection. Conversely, a positive nucleic-acid test should be assessed under the proper diagnostic workflow, not translated into a guaranteed prediction of mortality. Reports must preserve species, target, sample details, stage and confirmatory requirements. Exaggerated certainty can produce inappropriate farm responses and misleading communications.

These examples illustrate why disease labels are not interchangeable. AHPND involves a different aetiological framework from WSSV, and the relevant tissues, diagnostic methods and reporting duties can differ. A translation guide should not blend their lesion descriptions or use one disease’s PCR assay thresholds to interpret another’s results. Current specialist standards, not generic glossary substitutions, govern final diagnosis.

How pooled tests complicate animal-level percentages

Laboratories sometimes pool tissues from multiple animals into one test specimen. A positive pool means the target was detected in that combined material under the assay conditions. It does not identify exactly which animals in the pool contributed the target, nor how many individual animals are positive. If one of ten pools is positive and each pool contains five shrimp, it is incorrect to declare that exactly ten percent of shrimp were infected.

Pooling changes the sampling unit from animal to composite test. The number of pools and the number of animals per pool both matter, as do the assay’s validation and possible dilution effects. A report should say ‘one of ten pooled specimens tested positive, five animals per pool’ if those are the observations. Converting the result into individual prevalence requires a statistical model or follow-up evidence with explicit assumptions.

Consider four positive pools among twenty, each made from five animals. Twenty percent of pools are positive, but the individual positive count is not observed. Assuming every animal in a positive pool is infected would overstate one plausible bound, while assuming exactly one positive animal in each pool would impose an unverified minimum. The true pattern is not identified from these pooled outcomes alone.

Keep pool IDs and constituent animal IDs when possible. That enables later confirmation or tracing without rewriting old records. ‘Sample 12 positive’ is ambiguous when Sample 12 might represent one shrimp, one tissue section, one pool or one tank. Translators should expand shorthand using laboratory documentation and mark remaining ambiguity. A clean table can prevent serious errors in surveillance summaries.

Sampling bias: the sick animals are easier to find

When a farm presents visibly affected shrimp for diagnosis, technicians may deliberately select moribund animals to increase the chance of observing informative lesions. That is a defensible diagnostic sampling purpose, but not a neutral cross-section of the farm population. A high lesion fraction among submitted animals should not be narrated as the prevalence in the pond unless the design justifies extrapolation.

Surveillance of apparently healthy animals has another purpose. It may require a defined sampling design, validated assays and specified confidence in detecting infection above an intended prevalence threshold. The laboratory techniques may overlap with those used during clinical diagnosis, but the inferential target changes. A negative surveillance result is not identical to a confirmed absence of infection in every animal.

Case selection also influences statistical comparisons. If one set includes only symptomatic shrimp and another includes a random group from a different tank, differences in lesion frequencies may reflect selection before any biological treatment effect. A good table records the sampling frame, eligibility criteria and reasons for submission. Without these, attractive percentages offer limited evidence about why the groups differ.

Professionals also distinguish a case definition from a sample description. A case definition specifies which evidence qualifies an individual or event for classification under a particular surveillance or diagnostic system. ‘Appears unhealthy’ is a descriptive observation, not a complete disease-specific case definition. Translation should preserve formal criteria rather than replacing them with familiar everyday words.

How to interpret test performance without inventing a gold standard

Diagnostic sensitivity concerns the probability a test is positive among truly affected or infected subjects as defined by a suitable reference framework; diagnostic specificity concerns the probability a test is negative among truly unaffected subjects under that framework. Analytical sensitivity concerns the assay’s ability to detect a target at low amounts. These concepts differ. A report with only a group of positive and negative PCR results does not contain enough information to calculate them reliably.

If a method is validated against one reference standard, its reported performance may depend on population, specimen and test purpose. A sensitivity estimate from clinically ill shrimp should not automatically be applied to low-level infection surveillance among healthy animals. Changing the sampling population changes the problem. The reader should retain how and where the validation figures were obtained rather than presenting them as universal constants.

Positive predictive value depends on the pre-test prevalence or probability in the target population, in addition to sensitivity and specificity. A positive screening result in a low-prevalence population can have a different interpretation from the same assay in a high-risk clinical group. This is not a reason to disregard positive tests. It is a reason to follow the appropriate confirmatory workflow rather than make categorical claims from a single result.

Do not compute sensitivity by dividing lesion-positive PCR-positive animals by every lesion-positive animal unless the lesion rule is actually a valid reference standard for the diagnostic target and purpose. If the lesion is nonspecific or misses early infection, that calculation would be an agreement statistic under an assumed standard, not necessarily true diagnostic sensitivity. State the assumption if such a descriptive comparison is reported.

Time and clinical outcome: do not turn a cross-section into prognosis

A pathology slide captures a specimen collected at a particular time. It does not, by itself, establish when an infection began, when tissue damage developed, or what will happen next. Temporal claims require appropriate longitudinal evidence and disease-specific understanding. A severe-looking lesion at one sampling point may have different implications from a similar feature at another stage of the same process.

Mortality percentages need their own numerator and denominator. Suppose twelve of a starting cohort of two hundred shrimp are found dead over a stated interval. Observed mortality is six percent of the starting cohort, subject to the study’s accounting and recovery method. That number is not a lesion prevalence and cannot be derived from slide grades alone. A pathology report may help investigate cause, but it does not replace a properly maintained mortality record.

Be wary of survival statements built from specimens selected after animals died. If only carcasses were submitted, the sample is conditioned on mortality. A high PCR-positive share among those carcasses does not establish the fraction of living animals infected or prove that the detected agent caused every death. Case investigation needs contextual evidence, specimen integrity and qualified professional interpretation.

Treatment, disposal, movement controls and disease notifications are beyond the inferential capacity of a general reader’s pathology comparison. Such decisions should follow current aquatic animal health law, competent authority guidance and qualified laboratory results. Clear language supports those decisions; it does not create veterinary authority.

A translation checklist for multilingual pathology documents

Keep every animal ID, tissue name, sample date, fixation method, stain, lesion term, grade, diagnostic target and test result linked to the original observation. Translating a matrix into prose can accidentally separate a grade from its tissue or associate a PCR result with the wrong animal. A stable identifier is more important than elegant phrasing. Never remove the distinction between an individual specimen and a pooled specimen.

Expand abbreviations only after verifying them. HP may stand for hepatopancreas in a pathology report, while other disciplines use the same letters for entirely different concepts. WSSV, AHPND and PCR name distinct things; one is a viral agent, another a disease process and the last a laboratory technique. A glossary should state each expansion and preserve species and test-purpose context.

Many documents use the word positive casually. Write positive for what? An animal can be positive on a molecular assay, positive under a histological lesion rule or positive under a formal disease case definition. Each is a different classification. Good translation retains the precise object: ‘PCR target detected’, ‘characteristic lesion observed’, or ‘confirmed case under the stated protocol’.

Watch modal verbs and qualifiers. ‘May indicate’, ‘is compatible with’, ‘supports presumptive diagnosis’, ‘not detected’ and ‘confirmed following specified tests’ should not collapse into ‘has disease’. Precision protects scientists and farm staff from acting on claims the underlying report never established. When the source is ambiguous, carry that ambiguity forward with a note and seek specialist confirmation.

Errors and repairs: the order of evidence checks

Begin with identity. Match the correct shrimp, section, tissue, PCR sample and sample date. Next inspect the raw category labels and denominators. Recount the rows behind any prevalence or concordance percentage. Confirm whether grade zero means an adequate negative examination or a missing specimen. Many contradictions in summary tables disappear after correcting unit and identifier mismatches.

Then inspect methods. Were histology sections adequate? Were tissues comparable? Was PCR validated for the intended specimen and purpose? Were positive and negative controls acceptable? Was the target name correct? A method that produced an uninterpretable outcome should be labelled invalid or indeterminate according to its protocol, not quietly entered as negative.

Only after identity and method checks should the reader interpret discordance. Record the exact combination, such as target detected but no characteristic lesion observed, and note possible explanations as hypotheses. If disease-specific confirmation is needed, the authorised laboratory should advise. A translator must not improvise confirmatory testing instructions merely to tidy the written conclusion.

Preserve revisions in an audit trail. A correction from ‘twelve positive animals’ to ‘twelve positive sections from five animals’ can change the apparent prevalence dramatically. Retain original counts, corrected units, responsible reviewer and the reason for amendment. A strong report makes the repair transparent; it does not pretend the mistaken statistic never appeared.

Independent transfer problems with worked answers

Problem one: Thirty shrimp each contribute four histology sections. Eighteen sections across nine animals meet the lesion criterion. What is the section-level positive fraction? Eighteen divided by 120 equals 15%. What is the animal-level fraction? Nine divided by thirty equals 30%. Do not swap these numbers or call either a farm-wide infection prevalence without further evidence.

Problem two: A forty-animal group has lesion grades zero in sixteen animals, one in ten, two in nine and three in five. What fraction is grade two or above? Fourteen divided by forty equals 35%. What fraction has any recorded grade above zero? Twenty-four divided by forty equals 60%. The two answers refer to different thresholds, and neither is automatically a molecular infection rate.

Problem three: In fifty paired specimens, twelve are both PCR-positive and lesion-positive, ten are PCR-positive only, three are lesion-positive only and twenty-five are negative by both. Agreement is twelve plus twenty-five divided by fifty, or 74%. PCR positivity is twenty-two divided by fifty, or 44%; lesion positivity is fifteen divided by fifty, or 30%. Why is agreement not sensitivity? No independent truth standard was established.

Problem four: Three of fifteen pools, each representing four shrimp, are PCR-positive. What is directly measured? Twenty percent of pools tested positive, and the pool size was four. Can we report exactly twelve positive shrimp? No. The number of individual positives is not identified from pooled tests alone. Follow the validated interpretation and any confirmatory protocol rather than inventing an animal-level numerator.

Frequently asked questions

Is a PCR-positive, histology-negative shrimp healthy? The results alone do not justify that categorical conclusion. The PCR assay detected its specified target under its conditions, while the examined sections did not meet the particular lesion rule. Stage, tissue selection, method and other clinical evidence determine interpretation. A competent aquatic animal health laboratory should assess the complete case.

Does a severe lesion prove which pathogen caused it? Not automatically. Some lesions are nonspecific, while some characteristic patterns can support disease-specific interpretation under established methods. The diagnostic standard may require multiple forms of evidence. Preserve the lesion description and confirmation status instead of replacing it with a definitive pathogen name.

Why do two labs both call a lesion grade two but disagree? They may use different rubrics, tissues, fixation or scoring thresholds. Ordinal category labels cannot be assumed equivalent without common definitions and quality assurance. Compare the written criteria and study design before combining numerical grades.

Can I use forty tissue sections as a sample size of forty animals? Only if those sections genuinely represent forty independent animals, one per animal. Multiple sections from fewer animals are clustered observations. The distinction affects prevalence calculations and uncertainty. Always count animal IDs separately from section IDs.

Is one positive pooled sample equivalent to one infected animal? No. The pooled sample can contain material from several animals. Its positive status does not establish how many individual contributors are positive. Any further inference requires validated pooling interpretation and additional assumptions or tests.

Why must a report distinguish surveillance from clinical diagnosis? The target population, question, acceptable evidence and confirmatory procedures can differ. Screening apparently healthy animals is not the same as investigating clinically affected shrimp. WOAH disease-specific standards and qualified laboratory guidance should govern the relevant interpretation.